TOP
  • About
    • About
      • Philosophy
      • Culture
      • Transparency
      • Leadership Team
      • Partners
      • History and Global Brand
  • Sustainability
  • Innovation
    • Innovation
      • Pipeline
      • Clinical Trials
      • Fragile X Syndrome Clinical Trials
      • Clinical Trial Data Privacy Policy
      • Medical Information
      • Early Access Policy
      • Investigator Research
      • Educational Grants
      • Medical Writing Grants
  • News
    • News
      • News Posts
      • Social Media Community Guidelines
  • Products
  • Investors
  • Careers
  • Contact
United States
Worldwide
  1. HOME
  2. Committed to Scientific Excellence
  3. Fragile X Syndrome Clinical Trials
  4. Welcome to Shionogi Inc.

Welcome to Shionogi Inc.

Thank you for your interest in Tetra Discovery Partners, Inc. d/b/a Tetra Therapeutics (“Tetra”). Tetra was acquired by Shionogi & Co., Ltd. (“Shionogi”) in 2020 and all former Tetra clinical trials and research programs are now managed by Shionogi Inc., a U.S. subsidiary of Shionogi.

  • Fragile X Syndrome Clinical Trials
  • About Shionogi Inc.
  • About
  • Sustainability
  • Innovation
  • Products
  • Investors
  • News
  • Careers
  • Contact
  • Worldwide
  • Privacy Policy
  • Terms of Use
© 2025 Shionogi Inc. Florham Park, NJ 07932. All Rights Reserved.